Cargando…
Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease
Azathioprine is a cornerstone of the therapy of Crohn's disease. Unfortunately, infections and malignancies are relatively common adverse effects related to this drug; however, cirrhosis is exceptionally reported as a side effect. We report the case of a 49-year-old male patient with ileocoloni...
Autores principales: | Roselli, Jenny, Innocenti, Tommaso, Lynch, Erica Nicola, Parisio, Laura, Macrì, Giuseppe, Milla, Monica, Mello, Tommaso, Galli, Andrea, Milani, Stefano, Tarocchi, Mirko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008285/ https://www.ncbi.nlm.nih.gov/pubmed/32082651 http://dx.doi.org/10.1155/2020/6726384 |
Ejemplares similares
-
Stevens–Johnson Syndrome and Herpes Simplex Type 1 Infection during Adalimumab Therapy for Crohn's Disease
por: Roselli, Jenny, et al.
Publicado: (2020) -
Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey
por: Innocenti, Tommaso, et al.
Publicado: (2022) -
Main factors influencing long-term outcomes of liver transplantation in 2022
por: Fuochi, Elisa, et al.
Publicado: (2023) -
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
por: Campani, Claudia, et al.
Publicado: (2020) -
Gastric and duodenal polyps in familial adenomatous polyposis patients: Conventional endoscopy vs virtual chromoendoscopy (fujinon intelligent color enhancement) in dysplasia evaluation
por: Lami, Gabriele, et al.
Publicado: (2017)